「message」の検索結果
65件：51～55件目を表示
もしかして
-
Mytear ALPITATTO EXα | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® ALPITATTO EXα Works on unbearable eye itching due to pollens and other
http://www.senju.co.jp/english/products/apex.html -
Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical
We will contribute to medical care and your health requirements in the new era through medical devices. Today, in the era of the 100-year-life, digital transformation is being promoted in various fiel
https://www.senju.co.jp/english/about/business/device.html -
千寿製薬株式会社
NEWS & RELEASE June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease throug
http://www.senju.co.jp/english/ -
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r
https://www.senju.co.jp/english/products/mytearv.html -
研究开发体制 | 研究与开发 | 千寿制药株式会社
眼未来，早日为受疾病困扰的患者送去真正为人们所需要的创新性药品——这就是我们的使命。 执行董事 创新药研究本部 本部长 德重 秀树 ／ 执行董事 研究开发本部 本部长 关弥 卓郎 究开发部门 Top Message 大家好。研究开发部门（创新药研究本部、研究开发本部）以实现本公司原创愿景“为世界人民带来清爽五感”为目标，致力于“在五感领域凭借独特的思维和通行于世界的研究开发能力，持续创造并提供独创...
https://www.senju.co.jp/chinese/rd/about/